Log in to save to my catalogue

1280 Survival impact of residual disease after primary debulking surgery in advanced-stage low grade...

1280 Survival impact of residual disease after primary debulking surgery in advanced-stage low grade...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2954885510

1280 Survival impact of residual disease after primary debulking surgery in advanced-stage low grade serous ovarian cancer: a meta-analysis

About this item

Full title

1280 Survival impact of residual disease after primary debulking surgery in advanced-stage low grade serous ovarian cancer: a meta-analysis

Publisher

Kidlington: BMJ Publishing Group Ltd

Journal title

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A419-A420

Language

English

Formats

Publication information

Publisher

Kidlington: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Introduction/BackgroundLow-grade serous ovarian cancer (LGSOC) is a recent histologic diagnosis. The surgical approach of this disease has been little investigated and modeled on the management of high-grade serous ovarian carcinoma. The prognostic impact of the largest dimension of residual disease after primary surgery is still debated. This stud...

Alternative Titles

Full title

1280 Survival impact of residual disease after primary debulking surgery in advanced-stage low grade serous ovarian cancer: a meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2954885510

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2954885510

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1136/ijgc-2024-ESGO.822

How to access this item